Intellia Therapeutics Inc

NTLA NASDAQ Santé & Biotech États-Unis US45826J1051
13.65 $
1.90 %

Intellia Therapeutics est une entreprise de biotechnologie qui se consacre au développement de thérapies utilisant la technologie CRISPR-Cas9 pour l'édition génomique.

Price history of Intellia Therapeutics Inc
Price history of Intellia Therapeutics Inc

Performance & Momentum

6 Months 50.90 %
1 Year 37.55 %
3 Years 71.00 %
5 Years 83.19 %

Similar stocks to Intellia Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone